Treatments (0)
Advice for Migraine
Migraine symptoms typically progress through four phases: prodrome, aura, headache, and postdrome, though not everyone experiences all phases. Prodrome symptoms may occur hours or days before the headache and include mood changes, food cravings, neck stiffness, increased thirst, and frequent yawning. Approximately one-third of sufferers experience aura—visual disturbances such as flashing lights, zigzag lines, or temporary vision loss—or sensory, motor, or speech disturbances before the headache. The headache phase features moderate to severe throbbing or pulsating pain, typically on one side of the head, worsened by physical activity, light, sound, and sometimes smells. Accompanying symptoms often include nausea, vomiting, sensitivity to light (photophobia) and sound (phonophobia), and dizziness. The postdrome phase may leave the person feeling drained, confused, or moody for up to a day after the headache subsides.
Migraine FAQs (7)
Migraines are much more than just severe headaches. While tension headaches typically cause mild to moderate pain on both sides of the head, migraines often produce moderate to severe throbbing pain, usually on one side. Migraines are also accompanied by additional symptoms such as nausea, vomiting, sensitivity to light and sound, and sometimes visual disturbances (aura). Migraines can last from 4 to 72 hours if untreated and may significantly impair daily activities, while most tension headaches don't cause substantial disability.
Imigran Nasal Spray contains sumatriptan, which belongs to a class of medications called triptans. It works by activating serotonin receptors, which reduces inflammation and constricts blood vessels in the brain that have become abnormally dilated during a migraine attack. The nasal spray formulation allows the medication to be absorbed directly through the nasal membranes, providing faster relief than oral tablets—typically within 15 minutes. This makes it particularly useful for rapidly developing migraines or those accompanied by nausea and vomiting.
Currently, there is no cure for migraines, but they can be effectively managed with appropriate treatment and lifestyle modifications. Many people find that their migraine patterns change throughout their lifetime, sometimes improving with age. With proper management strategies, including identifying triggers, preventive medications when appropriate, and effective acute treatments, most people with migraines can significantly reduce the frequency and severity of their attacks and improve their quality of life.
Migraines themselves are not life-threatening, though they can severely impact quality of life. However, in rare cases, certain types of migraines may be associated with a slightly increased risk of stroke, particularly in women who have migraines with aura and also smoke or use oestrogen-containing contraceptives. It's important to note that severe headaches with unusual symptoms like fever, stiff neck, confusion, seizures, double vision, weakness, numbness, or trouble speaking should be evaluated immediately, as they could indicate a more serious condition.
Yes, approximately one-third of migraine sufferers experience aura—temporary sensory or visual disturbances that typically occur before the headache phase. Visual aura may include seeing flashing lights, zigzag lines, blind spots, or even temporary partial vision loss. These symptoms usually develop gradually over 5-20 minutes and resolve within an hour. Some people experience aura without developing a headache afterward, which is known as an ocular or silent migraine. While alarming, these visual changes are typically harmless and resolve completely.
National Health Service (NHS)
Migraine overview: https://www.nhs.uk/conditions/migraine/
Migraine treatments: https://www.nhs.uk/conditions/migraine/treatment/
National Institute for Health and Care Excellence (NICE)
Migraine management: https://cks.nice.org.uk/topics/migraine/
Headaches in over 12s: https://www.nice.org.uk/guidance/cg150
The Migraine Trust
General information: https://migrainetrust.org/
Types of migraine: https://migrainetrust.org/understand-migraine/types-of-migraine/
British Association for the Study of Headache (BASH)
Guidelines for healthcare professionals: https://www.bash.org.uk/guidelines/
British National Formulary (BNF)
Sumatriptan (Imigran): https://bnf.nice.org.uk/drugs/sumatriptan/
Migraine treatments: https://bnf.nice.org.uk/treatment-summaries/migraine/
Medicines and Healthcare products Regulatory Agency (MHRA)
Imigran product information: https://products.mhra.gov.uk/
The International Headache Society
Classification of headache disorders: https://ichd-3.org/
Patient.info
Migraine information: https://patient.info/brain-nerves/migraine-leaflet
Migraine management: https://patient.info/brain-nerves/migraine-leaflet/treatments-for-migraine